{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T14:34:19Z","timestamp":1761834859414,"version":"build-2065373602"},"reference-count":19,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,9,27]],"date-time":"2014-09-27T00:00:00Z","timestamp":1411776000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.tranon.2014.09.004","type":"journal-article","created":{"date-parts":[[2014,12,9]],"date-time":"2014-12-09T23:06:39Z","timestamp":1418166399000},"page":"741-751","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["The effect of Bortezomib and Rapamycin on Telomerase Activity in Mantle Cell Lymphoma"],"prefix":"10.1016","volume":"7","author":[{"given":"Orit","family":"Uziel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Einat","family":"Beery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jardena","family":"Nordenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meir","family":"Lahav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tranon.2014.09.004_bb0010","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1023\/A:1006321828515","article-title":"Proteasome inhibition: A new strategy in cancer treatment","volume":"18","author":"Adams","year":"2000","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.tranon.2014.09.004_bb0040","first-page":"15","article-title":"The biochemical and cellular basis of Cell Proliferation assays that use tetrazolium salts","volume":"4","author":"Berridge","year":"1996","journal-title":"Biochemical"},{"key":"10.1016\/j.tranon.2014.09.004_bb0050","series-title":"96th American Association of Cancer Research Meeting, Anaheim, CA, USA","article-title":"hTERT phosphorylation by PKC is essential for telomerase holoprotein integrity and enzyme activity in head neck cancer cells","author":"Chang","year":"2005"},{"key":"10.1016\/j.tranon.2014.09.004_bb0060","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1128\/MMBR.66.3.407-425.2002","article-title":"Human Telomerase and Its Regulation","volume":"3","author":"Cong","year":"2002","journal-title":"Microbiol Mol Biol Rev"},{"key":"10.1016\/j.tranon.2014.09.004_bb0065","doi-asserted-by":"crossref","first-page":"961","DOI":"10.2144\/04376RV01","article-title":"Chromatin immunoprecipitation assay","volume":"37","author":"Das","year":"2004","journal-title":"Biotechniques"},{"key":"10.1016\/j.tranon.2014.09.004_bb0080","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/bjc.1998.183","article-title":"The proteasome inhibitor lactacystin induces apoptosis and sensitizes chemo- and radioresistant human chronic lymphocytic leukemia lymphocytes to TNF-a-initiated apoptosis","volume":"77","author":"Delic","year":"1998","journal-title":"Br J Cancer"},{"key":"10.1016\/j.tranon.2014.09.004_bb0155","doi-asserted-by":"crossref","first-page":"13085","DOI":"10.1074\/jbc.274.19.13085","article-title":"Akt protein kinase enhances human telomerase activity through phosphorylation of telomerase reverse transcriptase subunit","volume":"274","author":"Kang","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.tranon.2014.09.004_bb0165","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/nar\/28.3.669","article-title":"Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT)","volume":"28","author":"Kyo","year":"2000","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.tranon.2014.09.004_bb0170","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1182\/blood.V106.11.2411.2411","article-title":"Rapamycin Enhances the Cytotoxicity of Bortezomib and Rituximab on Mantle Cell Lymphoma (MCL) Cell Lines","volume":"106","author":"Ismail","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.tranon.2014.09.004_bb0180","doi-asserted-by":"crossref","first-page":"16729","DOI":"10.1074\/jbc.272.27.16729","article-title":"Protein phosphatase 2A inhibits nuclear telomerase activity in human breast cancer cells","volume":"272","author":"Li","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.tranon.2014.09.004_bb0255","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0378-1119(99)00357-1","article-title":"The Sp-family of transcription factors","volume":"238","author":"Suske","year":"1999","journal-title":"Gene"},{"key":"10.1016\/j.tranon.2014.09.004_bb0260","series-title":"Pathology and genetics of tumours of haematopoietic and lymphoid tissues","first-page":"168","article-title":"Mantle cell lymphoma","author":"Swerdlow","year":"2001"},{"issue":"26","key":"10.1016\/j.tranon.2014.09.004_bb0295","doi-asserted-by":"crossref","first-page":"6409","DOI":"10.1200\/JCO.2005.55.017","article-title":"Current Treatment Approaches for Mantle-Cell Lymphoma","volume":"23","author":"Witzig","year":"2005","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.tranon.2014.09.004_bb0310","first-page":"433","article-title":"Telomerase activity in normal human epithelial cells","volume":"13","author":"Yasumoto","year":"1996","journal-title":"Oncogene"},{"key":"10.1016\/j.tranon.2014.09.004_bb0320","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.leukres.2012.10.009","article-title":"Molecular characterization of chromosomal band 5p15.33: a recurrent breakpoint region in mantle cell lymphoma involving the TERT-CLPTM1L locus","volume":"37","author":"Schilling","year":"2013","journal-title":"Leuk Res"},{"key":"10.1016\/j.tranon.2014.09.004_bb0325","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1038\/bjc.2012.460","article-title":"Differential downregulation of telomerase activity by bortezomib in multiple myeloma cells-multiple regulatory pathways in vitro and ex vivo","volume":"107","author":"Weiss","year":"2012","journal-title":"Br J Cancer"},{"key":"10.1016\/j.tranon.2014.09.004_bb0330","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1046\/j.1365-2141.1999.01620.x","article-title":"Telomerase activity in chronic lymphoproliferative disorders of B-cell lineage","volume":"106","author":"Trentin","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tranon.2014.09.004_bb0335","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.humpath.2003.07.009","article-title":"Telomerase activity and proliferation index in aggressive mature B-cell lymphoma: comparison to germinal center phenotypic markers","volume":"34","author":"Chiu","year":"2003","journal-title":"Hum Pathol"},{"key":"10.1016\/j.tranon.2014.09.004_bb0340","first-page":"1097","article-title":"Anti-proliferative activity of haloperidol in B16 mouse and human SK-MEL-28 melanoma cell lines","volume":"27","author":"Nordenberg","year":"2005","journal-title":"Int J Oncol"}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523314000977?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523314000977?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T14:30:24Z","timestamp":1761834624000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523314000977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S1936523314000977"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2014.09.004","relation":{},"ISSN":["1936-5233"],"issn-type":[{"type":"print","value":"1936-5233"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of Bortezomib and Rapamycin on Telomerase Activity in Mantle Cell Lymphoma","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2014.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Neoplasia Press, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}